GRAFDERM - bioactive dressing for the treatment of chronic wounds

Vol 1, 2023 - 165301
Oral (On site Format)
Favorite this paper
How to cite this paper?
Abstract

Introduction: The treatment of chronic wounds is commonly performed topically, through the use of dressings and drugs that act systemically, helping in the process of tissue homeostasis. However, the use of advanced dressings that perform a topical active action on wounds has motivated research and the world pharmaceutical market. Since such wounds are difficult to heal, the patient usually suffers from chronic pain and has a high risk of infection by microorganisms. In addition, the costs associated with treatment have a significant impact, mainly on the public health system. Objectives: Thus, the present work aimed the production and physical-chemical and biological characterization of the GRAFDERM dressing, developed by our team of entrepreneurs from the Research Laboratory of Biomaterials and Bioproducts (Dept of Chemical Engineering of UFC) and BioHealing (UFC spinoff), in collaboration with the University of Florida, the Department of Physics (UFC) and the Padre Albino University Center (UNIFIPA). Methods: GRAFDERM is a dressing made from natural polymers containing graphene oxide anchored with silver nanoparticles as an active ingredient (GOAg). For physical-chemical characterizations of the dressing, thermogravimetric analyzes (TGA), Fourier Transform Infrared Spectroscopy (FTIR), Franz cell release assay, evaluation of the degree of swelling of the dressing, scanning electron microscopy (SEM) and antioxidant activity were performed. As for the biological properties, in vitro tests were performed demonstrating that the dressing is not cytotoxic to fibroblasts (L929) and has antimicrobial activity against Staphylococcus aureus (ATCC 25923) and Pseudomonas aeruginosa (ATCC 27853). Results: It is noteworthy that the fact that silver nanoparticles are anchored to graphene allowed GRAFDERM to present similar or better antimicrobial activity, although it contains a significantly lower amount of silver (37 µg/cm2) than other dressings on the market, such as: Biatain Ag+ (1200 µg/cm2), Aquacel® Ag Extra™ (1800 µg/cm2), Mepilex Ag+ Molnlycke® (1800 µg/cm2), Exufiber Ag+ Molnlycke® (200 µg/cm2). This excellent antimicrobial activity, even at low concentrations of Ag, reduces the toxicity that could be generated by this metal and this allows for longer use of the dressing (if necessary) without causing harm to the patient the inflammation tests, by measuring the activity of the myel . In operoxidase enzyme in vitro, GRAFDERM apparently induced an inflammatory response on the 1st day of the test, but at longer times (10 days) it showed an antiinflammatory activity. Tests continued until in vivo assays , with test of infected skin lesion in compared to two commercial dressings. mice, showing better performance of GRAFDERM Conclusions: Thus, GRAFDERM is expected to reduce the risk of infections and indirectly contribute to stimulating the synthesis of hyaluronic acid and collagen, improving tissue repair. In addition, it is expected that the product will contribute to improving patient adherence to treatment, considering the less invasive approach (topical application), rapid local response, reduced frequency of exchanges and healin g time. Keywords: Bioactive dressings. Graphene. Silver. C hronic wounds.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Empresa Brasileira de Pesquisa Agropecuária
  • 2 Universidade Federal do Ceará - UFC
  • 3 Centro Universitário Padre Albino (UNIFIPA)
Track
  • 2. Recent advances in medicinal product research: bioinformatics, bioengineering, nanotechnology and OMICs
Keywords
Bioactive dressings; Graphene; Silver; Chronic Wounds